204 related articles for article (PubMed ID: 27235704)
21. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
22. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
Candito M; Soler C; Deville A; Bekri S; Chambon P; Thyss A
Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
[TBL] [Abstract][Full Text] [Related]
23. [Rapid determination of 4-hydroxy-3-methoxymandelic (vanilmandelic) acid and 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid in urine by liquid chromatography with electrochemical detection].
Satokata I; Asami T; Otsuka T; Sakai K
Rinsho Byori; 1986 Jul; 34(7):817-22. PubMed ID: 3761638
[No Abstract] [Full Text] [Related]
24. 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients.
Verly IRN; van Kuilenburg ABP; Abeling NGGM; Goorden SMI; Fiocco M; Vaz FM; van Noesel MM; Zwaan CM; Kaspers GJL; Merks JHM; Caron HN; Tytgat GAM
Eur J Cancer; 2018 Feb; 90():102-110. PubMed ID: 29274926
[TBL] [Abstract][Full Text] [Related]
25. Determination of urinary vanillactic acid and plasma dihydroxyphenylalanine as markers of non-secreting neuroblastoma by high-performance liquid chromatography with electrochemical detection.
Jouve J; Bakri D; Herault J; Muh JP
J Chromatogr; 1991 Jul; 567(2):331-41. PubMed ID: 1939466
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
27. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
Tuchman M; Stoeckeler JS
Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
[TBL] [Abstract][Full Text] [Related]
28. Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
[No Abstract] [Full Text] [Related]
29. Simultaneous determination of vanillylmandelic acid, homovanillic acid and creatinine in urine by reversed-phase ion-pair chromatography.
Tokuda T; Tokieda T; Anazawa A; Yoshioka M
J Chromatogr; 1990 Sep; 530(2):418-23. PubMed ID: 2079515
[No Abstract] [Full Text] [Related]
30. Liquid-chromatographic analysis for urinary 4-hydroxy-3-methoxymandelic acid and 4-hydroxy-3-methoxyphenylacetic acid, and its use in investigation of neural crest tumors.
Soldin SJ; Hill JG
Clin Chem; 1981 Mar; 27(3):502-3. PubMed ID: 7471405
[No Abstract] [Full Text] [Related]
31. [Catecholamine excretion (vanilmandelic acid, VMS, and homovanillic acid, HVS) in urine of healthy children].
Metz O; Feuerstein M
Kinderarztl Prax; 1983 Aug; 51(8):387-9. PubMed ID: 6632542
[No Abstract] [Full Text] [Related]
32. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
33. The value of catecholamine metabolite determination on untimed urine collections in the diagnosis of neural crest tumours in children.
Kellie SJ; Clague AE; McGeary HM; Smith PJ
Aust Paediatr J; 1986 Nov; 22(4):313-5. PubMed ID: 3566681
[TBL] [Abstract][Full Text] [Related]
34. Stage and urinary catecholamine metabolite excretion in neuroblastoma. European Neuroblastoma Study Group.
Pritchard J; Barnes J; Germond S; Hartman O; de Kraker J; Lewis I; Lockwood L; Wallendszus K
Lancet; 1989 Aug; 2(8661):514-5. PubMed ID: 2570230
[No Abstract] [Full Text] [Related]
35. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
[TBL] [Abstract][Full Text] [Related]
36. [Chemotherapy of radically unresectible neuroblastoma in the 1st 18 months of life. Importance of quantitative determination of dopamine, vanilmandelic and homovanillic acids].
Zeder B; Käser H; Wagner HP
Helv Paediatr Acta; 1974 Jun; 29(2):95-104. PubMed ID: 4436123
[No Abstract] [Full Text] [Related]
37. Mass screening for neuroblastoma in Japan.
Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
[TBL] [Abstract][Full Text] [Related]
38. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
39. Failure to detect dopaminergic neuroblastoma in a mass-screening system.
Naito H; Takeda T; Hanai J
J Pediatr Surg; 1995 Sep; 30(9):1317-8. PubMed ID: 8523234
[TBL] [Abstract][Full Text] [Related]
40. Dopaminergic neuroblastoma as a poor prognostic subgroup.
Nakagawara A; Ikeda K; Tasaka H
J Pediatr Surg; 1988 Apr; 23(4):346-9. PubMed ID: 3385588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
